Weill Cornell Medicine at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Weill Cornell Medicine brings 13 presentations to ObesityWeek 2026 in National Harbor. Its program covers obesity drug treatment and its long-term results, from ten-year metabolic outcomes to diet quality in medically managed patients. It also reports how retatrutide affects knee osteoarthritis pain and how a leptin sensitizer adds to the benefits of semaglutide in obese mice.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Weill Cornell Medicine New York, NY | |
Medical school of Cornell University in New York City. | Session Sun Nov 15 9:30am–10:30am Poster Sun Nov 15 2:30pm–3:30pm Monthly Berobenatide (MET-097, PF-08653944) in Adults with Obesity: VESPER-3 1st Results Interventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Psychotropic Medication Use and Long-Term Weight Loss Outcomes Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Diet Quality in Patients with Medically Managed Obesity Obesity pharmacotherapy and drug developmentPolicy and public health Poster Sun Nov 15 2:30pm–3:30pm Ten-Year Metabolic Outcomes with Obesity Pharmacotherapy Obesity pharmacotherapy and drug developmentPolicy and public health Talk Sun Nov 15 5:30pm–5:45pm Talk Sun Nov 15 5:30pm–5:40pm Talk Sun Nov 15 6:30pm–8:30pm Clinical Case Files: Following the Metabolic Clues in Obesity and MASLD Case-based problem-solving on spotting MASLD risk early and coordinating liver and metabolic care for patients with obesity. Metabolism and integrative physiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentChronic disease and obesity complications Talk Mon Nov 16 11:45am–12:45pm Glucagon’s Role in Metabolic Regulation and Why It Matters Covers how glucagon and the liver regulate glucose and fat metabolism and why this matters in obesity and related heart, kidney and metabolic diseases. Metabolism and integrative physiologyChronic disease and obesity complications Session Mon Nov 16 12:00pm–1:00pm TOS Clinical Practice Section Meeting (TOS members only) - Obesity Medicine in 2031: What Will It Look Like? A multidisciplinary panel looks ahead to obesity care in 2031, then the section recognizes its clinician and practitioner awards for obesity care. Clinical obesity care and professional practice Talk Mon Nov 16 1:45pm–2:00pm Dose to Dose: What We Know, What We Assume, How to Measure Change, and Future Directions Clinical obesity care and professional practiceObesity pharmacotherapy and drug development Poster Mon Nov 16 2:30pm–3:30pm Beyond BMI: FIB-4 Improves Heart Failure and Advanced CKM Identification in Type 2 Diabetes Chronic disease and obesity complications Talk Tue Nov 17 8:45am–9:00am Healthcare Delivery Models From JAMA Summit Clinical obesity care and professional practicePolicy and public healthObesity pharmacotherapy and drug development |
Find decision makers at Weill Cornell Medicine
Tell us what you sell and we’ll find the people at Weill Cornell Medicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction